Advertisement

Latest Articles in Pharma

Drugmaker Lupin's Profit Halves As US Sales Slump

Indian drugmaker Lupin reported its quarterly net profit nearly halved from a year ago, falling far short of analysts' expectations, as sales at its top market the United States slumped while the company's costs jumped

Read More

Lupin To Introduce Second Generation Antihistamine Tablets In India

The current market for plain antihistamines is estimated to be around Rs 860 crore growing at 14 percent during March 2017, according to IMS MAT.

Read More

Dr Reddy's Sees No Impact From Pricing Regulator Notice

Dr Reddy's Laboratories Ltd, India's second-largest drugmaker by sales, said it expects no impact from a recent government notice that said the company is selling a high blood pressure drug that lacks the pricing regulator's approval.

Read More

Himalaya Soon To Enter Cancer Therapy With Innovative Herbal Drugs

Backed by its well-known research strength in the natural science and Ayurveda, the company hopes to roll out at least five key drugs to fight out the alarmingly spreading disease

Read More

Merck Opens New M Lab Collaboration Centre In Bengaluru

The new M Lab Collaboration Centre in Bengaluru is one of the company’s 9 such centers around the world

Read More

Best CFO Awards 2016-17 | The M&A Man

How the leading pharma company relies on strong financials for growth

Read More

FDA Alerts On New Risks Of Cough And Cold Drugs Codeine, Tramadol In Children, Lactating Mothers

In India, these medications are generally prescribed by pediatritions as well as sold over the counter liberally for conditions like cold and cough without specific cautions and label warnings

Read More

Drugs For Cancer, Autism See Up To 86% Price Cut In A Year

Drug pricing regulator NPPA has slashed price of cancer drugs by up to 86 per cent since March last year providing relief to lakhs of patients

Read More

Torrent Pharma: The Growth Pill

The company, which came back to the fore after a long phase of stagnation, saw two critical accolades coming to it in the last four years. It found its top place among India’s fastest growing companies and its leader was named among the most promising CEOs in the country

Read More

Glenmark Pharma: A Healthy Dose Of Growth

Glenmark, which has graduated to a global organisation in a very short span with its expanded manufacturing footprint, international operations and global employee base, reported a 276.08 per cent rise in revenue since 2012

Read More

Glenmark Stock Up After US Approval To Its Savella Generic

Shares of drug maker Glenmark Pharmaceuticals rose 0.52 per cent to Rs 868. 45 a unit on BSE on Friday, a day that saw the benchmark Sensex down by at least 50 points

Read More

Vaccination For Delhi Belly May Soon Enter Market

The adult vaccine market in India is very small compared to the paediatric market, however, exact sales figures are not available

Read More

Pharma M&A Deals Touch $4.6 Billion In 2016

Indian players continued to look for access to under-penetrated markets and expand their product offerings

Read More